Finerenone was approved by the U.S. Food and Drug Administration (FDA) on July 19, 2024 [1].
What is Finerenone used for?
Finerenone is approved for the treatment of adults with chronic kidney disease (CKD) associated with type 2 diabetes [1].
How does Finerenone work?
Finerenone is a nonsteroidal selective mineralocorticoid receptor antagonist [1]. By blocking the mineralocorticoid receptor, it helps reduce inflammation and fibrosis in the kidneys, which can slow the progression of kidney damage in patients with type 2 diabetes [2].
When does Finerenone patent protection end?
Patent information for Finerenone can be tracked on DrugPatentWatch.com. Patent expiry dates determine when generic versions of the drug may become available [3].
What are the potential side effects of Finerenone?
The most common side effects reported include hyperkalemia (high potassium levels) and hypotension (low blood pressure) [1]. Patients taking finerenone will likely require regular monitoring of potassium levels [2].
What are the alternatives to Finerenone for diabetic kidney disease?
Other treatments for diabetic kidney disease aim to manage blood sugar, blood pressure, and reduce protein in the urine. These can include ACE inhibitors, ARBs, SGLT2 inhibitors, and GLP-1 receptor agonists [4]. Finerenone offers a new mechanism of action by targeting the mineralocorticoid receptor [2].
Who makes Finerenone?
Finerenone is manufactured by Bayer [1].
What clinical trials led to Finerenone's approval?
The approval of finerenone was based on data from clinical trials, including the FIDELIO-DKD and FIGARO-DKD studies [1]. These studies demonstrated the drug's efficacy in reducing the risk of kidney disease progression and cardiovascular events in patients with CKD and type 2 diabetes [5].
What are the regulatory considerations for Finerenone?
The FDA's approval followed a thorough review of the submitted clinical data. Regulatory agencies worldwide evaluate similar data to determine the safety and efficacy of new medications [6].
What is the cost of Finerenone?
The cost of finerenone will vary depending on insurance coverage and pharmacy pricing. Information on pricing can typically be found through patient assistance programs and insurance provider formularies [7].
Sources:
[1] https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-finerenone-treatment-chronic-kidney-disease-associated-type-2-diabetes
[2] https://www.drugpatentwatch.com/finerenone
[3] https://www.drugpatentwatch.com/
[4] https://www.niddk.nih.gov/health-information/kidney-disease/kidney-disease-diabetes/treatment
[5] https://clinicaltrials.gov/
[6] https://www.ema.europa.eu/en
[7] https://www.bayer.com/